Good morning. Prime Minister Mark Carney has finally secured a majority government, with the Liberals winning all three byelections last night. We'll get into that below, as well as why some U.S. companies actually like the Trump tariffs and a look at B.C.'s toxic drug emergency, 10 years on.

These U.S. companies think Trump's tariffs are great. Here's why

The White House is on a push to showcase a rarely seen sentiment: the success stories of U.S. manufacturers who are benefiting from President Donald Trump's tariff regime.

What's happening: Trade Representative Jamieson Greer went out on a two-day factory tour in Ohio and Michigan last week, and CBC News accompanied. It included a factory site for Whirlpool, the only major appliance firm to make the majority of its goods in the U.S. The company once felt it couldn't compete with Asian counterparts, its CEO told the tour's audience. The tariffs mean a potential manufacturing renaissance. Others included a solar power company and two defence firms.

Why it matters: Unlike his boss, Greer has laid out a consistent rationale for tariffs — to encourage more manufacturing in the U.S. Indeed, the companies he visited were already making their products at home even before Trump's second term. The tariff war didn't drive that decision, but it did make it pay off. Still, the administration will have a tougher time making the math work. Manufacturing jobs have declined since Trump returned to office.

B.C. declared toxic drugs a public health emergency 10 years ago. Has it made a difference?

Ten years ago on this day, B.C. became the first province in Canada to declare a public health emergency over toxic drugs. But experts worry the province hasn't used all its available powers in that time to fix the crisis.

What's happening: More than 18,000 people in B.C. have died from toxic drugs since April 2016, when the emergency was declared. Most of them were men, aged 30 to 59, and about half of them died in private residences, according to the B.C. Centre for Disease Control. A big issue is the unregulated drug supply, the makeup of which is constantly changing, experts say. The big threat was once fentanyl; in recent years it's been carfentanil and medetomidine. 

Why it matters: Some experts say the B.C. government's response to the crisis has been inadequate, saying it pales in comparison to the sweeping public health measures placed during the COVID-19 pandemic. Some also fear that politicians are catering to public opinion rather than science in making decisions on the issue, such as ending of province's three-year drug decriminalization pilot project.